SCHEMBL24106554

SCHEMBL24106554

CC(C)Nc1ccc(C(F)(F)F)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 3/20 0.53
MAPT P10636 3/20 0.50
ALDH1A1 P00352 2/20 0.50
LMNA P02545 2/20 0.45
NPSR1 Q6W5P4 2/20 0.43
KMT2A Q03164 2/20 0.43
POLB P06746 2/20 0.43
MEN1 O00255 1/20 0.43
TP53 P04637 1/20 0.43
GAA P10253 1/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAP2K1 Q02750 2/20 0.42
KIF11 P52732 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.39
HTR2A P28223 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14996620 0.90 PDE2A (0.50) PDE2AMAPTALDH1A1LMNANPSR1
SCHEMBL12856309 0.86 PDE2A (0.50) PDE2AMAPTALDH1A1LMNANPSR1
SCHEMBL3232155 0.86 LMNA (0.58) PDE2AMAPTALDH1A1LMNANPSR1
Ammonia Solution, Strong SCHEMBL3234716 0.84 LMNA (0.57) PDE2AMAPTALDH1A1LMNANPSR1
SCHEMBL20393776 0.84 CYP2C19 (0.37) PDE2AMAPTALDH1A1LMNANPSR1
SCHEMBL10848846 0.83 PDE2A (0.47) PDE2AMAPTALDH1A1LMNANPSR1
SCHEMBL12859563 0.83 PDE2A (0.47) PDE2AMAPTALDH1A1LMNANPSR1
SCHEMBL12856451 0.83 PDE2A (0.47) PDE2AMAPTALDH1A1LMNANPSR1
SCHEMBL10954628 0.82 PDE2A (0.46) PDE2AMAPTALDH1A1LMNANPSR1
SCHEMBL13483717 0.81 KIF11 (0.43) PDE2AMAPTALDH1A1LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210386065-A1 MIXTURE OF MECTINS AND PYRETHROIDS AND USES THEREOF VALENT BIOSCIENCES LLC 2021-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210386065-A1 MIXTURE OF MECTINS AND PYRETHROIDS AND USES THEREOF ACHE, DDT, PTMS PDE2A 625/4885MAPT 2689/4885ALDH1A1 4548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.